EGFR Mutation Testing Practices within the Asia Pacific Region: Results of a Multicenter Diagnostic Survey

INTRODUCTION: The efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutation-positive non–small-cell lung cancer (NSCLC) patients necessitates accurate, timely testing. Although EGFR mutation testing has been adopted by many laboratories in Asia, data are lacking...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Oncol
Main Authors: Yatabe, Yasushi, Kerr, Keith M., Utomo, Ahmad, Rajadurai, Pathmanathan, Tran, Van Khanh, Du, Xiang, Chou, Teh-Ying, Enriquez, Ma. Luisa D., Lee, Geon Kook, Iqbal, Jabed, Shuangshoti, Shanop, Chung, Jin-Haeng, Hagiwara, Koichi, Liang, Zhiyong, Normanno, Nicola, Park, Keunchil, Toyooka, Shinichi, Tsai, Chun-Ming, Waring, Paul, Zhang, Li, McCormack, Rose, Ratcliffe, Marianne, Itoh, Yohji, Sugeno, Masatoshi, Mok, Tony
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2015
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4342317/
https://ncbi.nlm.nih.gov/pubmed/25376513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000422
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados